NYSE (USD): Theriva Biologics, Inc. (TOVX)
Last Price
1.26
Today's Change
0.00 (0.00%)
Day's Change
1.25 - 1.31
Trading Volume
41,749
You are setting up a price and signal alert with 15 minutes delay. Click here to enjoy real-time price and signal alerts.
T4Q
31-Mar-2021
2020
2019
2018
2017
Revenue
238
1000
110
900
600
MQ Chat
Send individual or group chats with anyone on i3investor
MQ Trader
Earn MQ Points while trading with MQ Trader
MQ Affiliate
Earn side income from Affiliate Program
MQdemy
Online learning and teaching marketplace
1
CEO Morning Brief
US Got the World Driving. Now It’s Going Home — David Fickling
2
Goldman Says ‘go for Gold’ as Central Banks Buy, US Fed Cuts in 2025
3
Netflix Rival Max Rolls Out in Asia With Slate of Blockbusters
4
Gold Rebounds After Deep Weekly Loss With Rate Outlook in Flux
5
Trump Team Is Seeking to Ease US Rules for Self-driving Cars, Bloomberg Reports
#
Stock
Score
GRAB
Grab Holdings Limited
AAPL
Apple Inc.
800
ADPI
BABA
Alibaba Group Holding Limited
520
PLTR
Palantir Technologies Inc.
480
6
NVDA
NVIDIA Corporation
440
7
ES
Eversource Energy
400
8
CPX
9
CTX
10
AGN
Last
Change
Volume
TNXP
0.198
+0.035
587,137,325
MSTZ
0.726
-0.284
307,194,415
QSI
1.43
+0.802
250,467,727
DBGI
0.143
+0.027
234,990,845
SLXN
0.302
+0.073
181,789,339
144.73
-2.28
159,719,598
ELAB
0.021
0.00
137,065,425
LMDX
0.016
-0.018
120,553,903
LILM
0.209
-0.334
112,784,715
MARA
23.36
+3.50
89,299,287
MSTR
495.04
+64.50
48,095,166
MSTU
271.87
+61.37
9,582,122
MSTX
184.54
+42.38
9,173,247
FCNCA
2,259.24
+41.51
68,269
WSM
176.13
+38.89
5,968,387
TDG
1,285.71
+35.09
190,744
WIX
211.47
+27.52
1,952,309
LLY
752.39
+22.66
2,971,416
UNH
594.94
+17.94
1,885,311
HUM
291.38
+13.60
1,206,373
BRK-A
701,990.32
-1,969.687
1,069
MELI
1,774.05
-343.25
2,940,447
1,309.00
-138.99
2,237,917
MKL
1,395.13
-102.30
318,280
NOW
643.29
-87.83
5,025,012
762.00
-84.71
85,558,284
MEDP
357.30
-79.88
1,004,401
MDB
236.06
-73.94
10,812,930
MCK
547.51
-70.00
4,067,959
POWL
259.04
-53.095
928,591
CS Tan
4.9 / 5.0
This book is the result of the author's many years of experience and observation throughout his 26 years in the stockbroking industry. It was written for general public to learn to invest based on facts and not on fantasies or hearsay....